PALATIN TECHNOLOGIES, INC. Costs and Expenses
PALATIN TECHNOLOGIES, INC. (PTN) reported Costs and Expenses of $9.22 million for the 12-month period ending 2025-06-30, per its 10-K filed 2025-09-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2025-09-23
- PALATIN TECHNOLOGIES, INC. costs and expenses for the quarter ending 2025-06-30 was $0.00.
- PALATIN TECHNOLOGIES, INC. costs and expenses for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. costs and expenses for the quarter ending 2024-12-31 was $0.00.
- PALATIN TECHNOLOGIES, INC. costs and expenses for the quarter ending 2024-09-30 was $9.22M, a 1.26% increase year-over-year.
- PALATIN TECHNOLOGIES, INC. costs and expenses for fiscal 2025 was $9.22M, a 0.00% change from fiscal 2024.
- PALATIN TECHNOLOGIES, INC. costs and expenses for fiscal 2024 was $9.22M, a 1.26% increase from fiscal 2023.
- PALATIN TECHNOLOGIES, INC. costs and expenses for fiscal 2023 was $9.11M.
| Period end | Costs and Expenses 1 month | Costs and Expenses 1 month as first filed | Costs and Expenses 3 month | Costs and Expenses 6 month | Costs and Expenses 9 month | Costs and Expenses 12 month |
|---|---|---|---|---|---|---|
| 2025-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $0.00 derived: sum of 2 quarters · filed 2025-09-23 | $0.00 derived: sum of 3 quarters · filed 2025-09-23 | $9.22M 10-K · filed 2025-09-23 | ||
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-14 | $0.00 derived: sum of 2 quarters · filed 2025-05-14 | $9.22M 10-Q · filed 2025-05-14 | $9.22M derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | $9.22M 10-Q · filed 2025-02-13 | $9.22M derived: sum of 3 quarters · filed 2025-02-13 | $13.87M derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2024-09-30 | $9.22M 10-Q · filed 2024-11-14 | $9.22M derived: sum of 2 quarters · filed 2024-11-14 | $13.87M derived: sum of 3 quarters · filed 2024-11-14 | $9.34M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2024-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $4.65M derived: sum of 2 quarters · filed 2024-09-30 | $114.94K derived: sum of 3 quarters · filed 2024-09-30 | $9.22M 10-K · filed 2024-09-30 | ||
| 2024-03-31 | $4.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-15 | $114.94K derived: sum of 2 quarters · filed 2024-05-15 | $9.22M 10-Q · filed 2024-05-15 | $9.22M derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2023-12-31 | -$4.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-14 | $4.57M 10-Q · filed 2024-02-14 | $4.57M derived: sum of 3 quarters · filed 2024-02-14 | $4.57M derived: sum of 4 quarters · filed 2024-02-14 | ||
| 2023-10-31 | $9.11M 10-Q · filed 2025-02-13 | |||||
| 2023-10-20 | $4.57M 10-K · filed 2025-09-23 | $4.57T 10-Q · filed 2023-11-14 | ||||
| 2023-09-30 | $9.11M 10-Q · filed 2023-11-14 | $9.11M derived: sum of 2 quarters · filed 2023-11-14 | $9.11M derived: sum of 3 quarters · filed 2023-11-14 | |||
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $0.00 derived: sum of 2 quarters · filed 2023-09-28 | $9.11M 10-K · filed 2023-09-28 | |||
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-15 | $9.11M 10-Q · filed 2023-05-15 | ||||
| 2022-12-31 | $9.11M 10-Q · filed 2023-02-14 | |||||
| 2022-10-31 | $9.11M 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |